Why generic printer cartridges are not the same as generic drugs
Australian clinics and medical practices are subject to some of the most complex and stringent regulations so it makes sense that there would be such strict oversight, given that people visiting these facilities are likely to be doing so because they have health concerns and are therefore more susceptible than normal to hazardous substances. As a whole, Australian medical clinics are very good at meeting their obligations and responsibilities where the health of the patients is concerned. However, something that a lot of healthcare facilities do overlook is the toner used in printers, and while this might sound like something small, the risks are greater than you might assume. If health facilities are using the wrong toner, that easy-to-overlook printing component could be a bigger potential hazard than even the drugs administered and prescribed by the clinic.
Generic drugs vs generic toner: a comparison
Health clinics will often prescribe ‘generic’ drugs for medicines in which the relevant patents have expired. These drugs will have the same active ingredient as the commercial, ‘brand name’ version of the drug, but because these drugs were developed by companies that didn’t invest the R&D on the medicine, and are often sold without a marketing budget behind them, they’re typically cheaper.
The reason that health clinics don’t mind prescribing these is because a generic drug isn’t any more of a risk to the patient. Generic drugs still need to meet Australia’s extensive standards of quality, safety and effectiveness to be sold at all, so there’s no reason for the patient to spend more on the ‘brand drug’. Meanwhile, by prescribing something cheaper, the clinic and pharmacist come out looking good — they’re saving their patient money.
There are also ‘generic’ — or third-party — toners available on the market for use in printers. These are manufactured to fit into printers made by another company; for example, a third party might create a toner for use in a Brother printer. The appeal of these cartridges can be much the same as the appeal of generic drugs — they can be cheaper. Unlike the generic drugs, however, there isn’t the same legal or regulatory oversight in the production of toner, and this potentially creates significant problems for any clinic that buys a third-party toner.
The risks, explained
There are two principle risks where third-party toner is concerned. The first is the risk of toner leakage. In a report produced by Brother that tested its in-house toner against the quality of 10 third-party toners designed to operate on Brother’s platform, there was a substantial trend of toner leakage during use. As the report states: “At the end of testing, Brother was the only toner cartridge brand to leave the printer in a clean condition. Without exception, all third-party brands tested left toner deposits inside the machine.”
As a secondary risk, many of the third-party toner cartridges printed pages where the toner hadn’t bonded properly with the page, resulting in subsequent smudging, where Brother toner ensured that each page that was produced featured no smudging.
Purely from a commercial perspective, this means that third-party toner supplies are not good value for money. The toner deposits they leave in machines means that the machine needs to be cleaned more frequently, and will wear to the point of the machine itself needing replacement much faster. Additionally, the average third-party toner brand was tested to only produce 38% of the printed yield of Brother toner cartridges. This means that third-party toners need to be replaced more frequently, and there is a greater potential that the clinic will have periods where it’s unable to print, because it has run out of toner and is waiting for replacements.
In addition to the challenges posed by the sheer inefficiency of third-party toner, in an environment in which precision and detail in records is critical, the propensity for smudging from third-party toner cartridges means that reprints will often become necessary. In a clinic, where patient data security is paramount, this also has a knock-on effect of requiring the management and destruction of more pages of paper.
There’s more to it than just the commercial inconvenience and inefficiency of third-party consumables, though. The big concern for clinics and healthcare from these poorly manufactured third-party toners is the potential health risks of the toner itself.
The risks of cheap toner in healthcare
Properly used, toner is a very safe material for printing. As long as the toner has bonded properly with the page, so excess particles are not susceptible to being blown off or smudged onto the fingers, there’s no inherent risk in using toner.
However, poor-quality toner cartridges, which leave deposits in printing devices or smudge off the page, are a different story. Through operation, these cartridges introduce toner particles into the air and to people via contact. Large quantities of inhaled toner caries a risk of irritation to the respiratory system, increased difficulty in breathing, sneezing and coughing. Toner that comes into eye contact might cause eye irritation, and ingested toner can cause a stomach ache.
In a typical environment these risks are small, and have minor implications. In a clinic, which is meant to be kept sterile and where heavy printing is common, and many of those in the environment are suffering health complaints, the risks are greater if there is a significant amount of loose toner dust in the environment.
This is a risk that the administrators of many medical centres aren’t even aware of, Brother Commercial Manager, Luke Howard, said. “Some Doctors or Office Administrators at clinics have the perception that generic toners go through the same stringent manufacturing and approval process as first-party toners,” he said. “They’re used to expecting safety and reliability from generic drugs, and expect the same to be true in other areas.
“In order to maintain the health safety standards of a clinical environment, it’s important to purchase genuine consumables from the original manufacturer,” Luke added. “In order for toner to fuse onto the page correctly, the compound of the toner is designed to be fused at the temperatures that is set in a laser printer; this is something that only the manufacturer can properly test during the manufacturing process.”
In addition to the potential health risks of direct contact with toner, there’s the risk that the poor print quality offered by third-party toner cartridges could lead to mistakes made, as patient information is incorrectly read. This could, potentially, lead to some significant consequences for the clinic and its patients.
Brother toner, putting safety first
Even with the digitisation of patient records, and the increasing reliance that we have on computers to cover healthcare from end to end, clinics still need to produce a great deal of printed paper. With an ever-increasing level of regulatory oversight ensuring that medical clinics are doing their utmost to protect their patients, it’s more important than ever that administrators consider the full environment.
As with any chemical, it’s important to operate toner with a focus on safety. Making sure that you’ve got consumables such as toner cartridges manufactured to exacting standards by the same manufacturer as the printer is important in ensuring that the risk of pollutants entering the environment is minimised.
For more information on Brother printers, and a comparison between Brother’s toner cartridges and third-party examples, get in touch with our experts at https://corpsolutions.brother.com.au/ or call 1300 885 989.
Small Strategies that Make a Big Impact on Healthcare Professionals' Well-Being and Retention
Making thoughtful changes to create healthier work environments for nurses and other caregivers...
3M Health Care is now Solventum
On 1 April 2024, Solventum completed its spin-off from 3M and became the newly independent...
Workplace Health & Safety Show 2024
Workplace Health & Safety Show returns to Sydney Showgrounds on 23–24 October 2024,...